NCT06953180View on ClinicalTrials.gov

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

RecruitingOBSERVATIONAL
Enrollment

6,720

Participants

Timeline

Start Date

March 3, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

December 31, 2026

Conditions
Cardiovascular Diseases (CVD)Type 2 DiabetesChronic Respiratory DiseasesObesity (Disorder)Chronic Kidney Diseases
Interventions
OTHER

Genetic: DNA analysis

Investigation of telomere length (TL) and DNA methylation level analysis

Trial Locations (1)

050000

RECRUITING

Asfendiyarov Kazakh National Medical University, Almaty

All Listed Sponsors
lead

Asfendiyarov Kazakh National Medical University

OTHER